Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. - Wikidata - awgldk - TriplyDB

Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction.

Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction.

http://www.wikidata.org/entity/Q33495813

about

Thrombopoietin as biomarker and mediator of cardiovascular damage in critical diseases Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes The Centenary of Immune Thrombocytopenia - Part 1: Revising Nomenclature and Pathogenesis Eltrombopag in aplastic anemia Numerical analysis of in vivo platelet consumption data from ITP patients Suspects in the tale of lupus-associated thrombocytopenia.New insights into the mechanisms of nonimmune thrombocytopenia in neonates.Pathobiology of secondary immune thrombocytopenia.Treatment of immune thrombocytopenic purpura: focus on eltrombopag.Thrombopoietin and platelet production in chronic immune thrombocytopenia.New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents.Eltrombopag--a novel approach for the treatment of chronic immune thrombocytopenic purpura: review and safety considerations.Decreased plasma cytokines are associated with low platelet counts in aplastic anemia and immune thrombocytopenic purpura.Increased plasma thrombopoietin levels in patients with myelodysplastic syndrome: a reliable marker for a benign subset of bone marrow failure.Active thrombopoiesis is associated with worse severity and activity of chronic GVHD.Serum Thrombopoietin and cMpl Expression in Thrombocytopenia of Different Etiologies Thrombopoietin: a potential diagnostic indicator of immune thrombocytopenia in pregnancy.Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug.Regulation of hematopoietic stem cells by their mature progeny Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma.Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia.Increased differentiation of dermal mast cells in mice lacking the Mpl gene.Circulating thrombopoietin levels in normal healthy blood donors and in aplastic anemia patients in relation to disease severity Recombinant human thrombopoietin treatment promotes hematopoiesis recovery in patients with severe aplastic anemia receiving immunosuppressive therapy.Eltrombopag and improved hematopoiesis in refractory aplastic anemia.Intron V, not intron I of human thrombopoietin, improves expression in the milk of transgenic mice regulated by goat beta-casein promoter Protected graft copolymer-formulated fibroblast growth factors mitigate the lethality of partial body irradiation injury.Romiplostim dose-response in patients with myelodysplastic syndromes Platelet turnover in stable coronary artery disease - influence of thrombopoietin and low-grade inflammation.Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation.The haematopoietic stem cell niche: new insights into the mechanisms regulating haematopoietic stem cell behaviour Pharmacokinetic model of target-mediated disposition of thrombopoietin.Thrombopoietin levels in Quebec platelet disorder-Implications for the mechanism of thrombocytopenia.Persistent elevation of plasma thrombopoietin levels after treatment in severe aplastic anemia.D-dencichine Regulates Thrombopoiesis by Promoting Megakaryocyte Adhesion, Migration and Proplatelet Formation.Use of Eltrombopag in Improving Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation.A cross-sectional retrospective study to analyze the underlying causes and clinical characteristics of children with reactive thrombocytosis at a Korean tertiary medical center

P2860

Q21296645-BBAE6856-58C4-4BBA-9617-87D6C24D60EA Q26863182-7CD7B94D-4376-48C7-A02F-E9F63EE8FA58 Q28068881-967C38D4-FF49-4A69-9F53-353F3461120F Q28085299-4C42C2E0-E155-4164-8863-D61DD91430B1 Q31010919-66C70556-D0CA-42E0-B9B1-53B1B3E9DAAF Q33371650-BC53196F-EF1A-4F91-9452-475438808D4A Q33382906-1D8849DB-FF8E-4933-9A1D-AA288E04C9A7 Q33383468-1885B8A2-19AA-4C1F-A611-38ACEC4829F4 Q33385976-3E5792AD-8155-4015-9631-1ED69C7E7264 Q33387153-21F93C02-FBF0-49E0-8A2B-F6C1019EB8B2 Q33387735-D4D6EFE0-BBC0-4050-9896-4B3C9095D42B Q33391229-CFD74366-BC11-4AF3-8909-35FFB5636877 Q33400949-89EE118E-30D8-45F9-8014-583F6CACDAA0 Q33405829-3D8CF87D-897B-4E6E-86B2-999C3F0E881C Q33408944-9B35EA74-1ED3-4122-8AF3-AF47E657F638 Q33414491-F1CFEE49-B718-43F5-B4DD-8DD4F0E3A87A Q33429738-28674CA3-0495-4EA6-84B9-EC69AB3BB141 Q33439412-96554964-ED55-4B2B-A2AF-921DD21AF270 Q34392449-F0376B78-1632-4F58-B9BE-8DB1011E285D Q34411237-B04FE4EB-570F-4056-8F59-86E4A67B3029 Q34549999-54D34DBE-D713-495E-9940-18BD4F876A77 Q34555435-53F2057B-DDD1-4226-AA67-C3C8D844A67F Q35101887-0321E741-1D2F-4898-A765-25606873D32D Q35119918-9E9726F8-385B-4BE0-B793-18C1C33C10AB Q35226647-94D4610C-BBB8-46BA-9317-F4524D9A861F Q36174878-A7AB532D-15FF-4420-8919-B37DFAE2B2C1 Q36242078-7DCF9BD2-3DEF-4669-B7AB-484F4C7ED55F Q36282619-4278C7A0-3BE8-4716-9389-6DFD003D32D5 Q36948110-3B2F9421-4787-4A71-B2AF-B2CDE6C52827 Q37499510-BD412286-5B20-4BDD-865E-CCD68100B361 Q37725327-20059826-4515-49F7-98E6-40E1DABA889A Q37963879-7263C3F7-1C0B-4783-9417-932C6DD134D7 Q42564517-9B7202A3-F97D-4C35-B80C-65FC62FF61F1 Q48125691-821B458F-3C38-48FF-983D-F3563960576B Q49893762-6C587C7D-35A2-4297-822B-55EA6D0F82EF Q52581888-F2439F0D-109D-405F-AA7B-4BC63D2091E9 Q52717647-12C16335-8843-4FDD-9A94-F59C48CAD8DE Q57494286-DB14D6F7-DACC-473A-8920-76395645A37A

P2860

Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction.

http://www.wikidata.org/entity/Q33495813

description

1996 nî lūn-bûn

@nan

1996 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年学术文章

@wuu

1996年学术文章

@zh-cn

1996年学术文章

@zh-hans

1996年学术文章

@zh-my

1996年学术文章

@zh-sg

1996年學術文章

@yue

name

Human thrombopoietin levels ar ...... ncreased platelet destruction.

@ast

Human thrombopoietin levels ar ...... ncreased platelet destruction.

@en

type

label

Human thrombopoietin levels ar ...... ncreased platelet destruction.

@ast

Human thrombopoietin levels ar ...... ncreased platelet destruction.

@en

prefLabel

Human thrombopoietin levels ar ...... ncreased platelet destruction.

@ast

Human thrombopoietin levels ar ...... ncreased platelet destruction.

@en

P1433

Q33495813-000FE32D-9D3C-4E4E-BE8B-A0ED3A80104A

P1476

Q33495813-8E390AB1-93E1-4B27-A5D1-B92BD92A5630

P2093

Q33495813-1D9DE546-C5B2-422D-803D-B52CAB4E08F1

Q33495813-39BDEDAB-D7D1-4987-B959-9E8EB8D1583E

Q33495813-A96F3677-84E0-40F9-A1C9-4C2822C7779B

Q33495813-C8EED977-5489-43CC-BD35-590B5B774A36

Q33495813-D3AACF13-83DB-455B-B355-99F724A48BD2

Q33495813-EA7A9056-865B-4607-A98F-9631310C1E46

P304

Q33495813-E5E101CF-61B9-4B93-BF72-510876FF9B5C

P31

Q33495813-0737F33E-19B9-40D6-A64F-F08F973AAFEF

P407

Q33495813-5D9FAAAF-23E7-472B-AB4C-D2CF58BD67AB

P433

Q33495813-20864683-1D9F-4A7E-ADFC-CF83E2754298

P478

Q33495813-8569936F-63CA-4FF8-99DE-F226BCCA423D

P50

Q33495813-1E9C7A24-25FE-4672-8245-AA35226CCBEE

P577

Q33495813-811C19CC-CCB5-4FCE-A8F1-7F05184264D6

P698

Q33495813-C528F0B5-9A1E-403E-A689-430E3401F6A1

P921

Q33495813-B5EEC2A9-9C79-429A-AA3C-CB74A581AD6A

P1433

P1476

Human thrombopoietin levels ar ...... increased platelet destruction

@en

P2093

Cohen RL

http://www.w3.org/2001/XMLSchema#string

Emmons RV

http://www.w3.org/2001/XMLSchema#string

Meng G

http://www.w3.org/2001/XMLSchema#string

Reid DM

http://www.w3.org/2001/XMLSchema#string

Shulman NR

http://www.w3.org/2001/XMLSchema#string

Young NS

http://www.w3.org/2001/XMLSchema#string

P304

4068-4071

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P50

Cynthia E Dunbar

P577

1996-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8639762

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia